
Work Here?
Work Here?
Work Here?
Condor Software provides a cloud-based financial intelligence platform for biopharma, MedTech, and CROs. It unifies clinical, operational, and financial data into a single source of truth and automates processes like clinical accruals, financial planning and forecasting, vendor management, and audits, with integrations to ERP and CTMS for real-time visibility into R&D spend. It differentiates itself with Copilot, Compass, and Connect to automate accruals, forecast costs, and integrate data across systems, helping customers achieve outcomes such as 90% forecast accuracy and a 70% faster month-end close. Its goal is to streamline fragmented clinical finance workflows, reduce manual work, ensure compliance, and provide real-time financial insight to support faster drug development, serving emerging to enterprise biopharma, MedTech, and CRO customers on a SaaS model.
Industries
Data & Analytics
Enterprise Software
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$24M
Headquarters
San Diego, California
Founded
2020
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$24M
Above
Industry Average
Funded Over
1 Rounds
Industry standards
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
401(k) Company Match
Unlimited Paid Time Off
Condor Software has launched its Advanced Analytics and Dynamic Scenario Suite, completing its AI-powered platform for life sciences R&D finance teams. The announcement follows the company's $24 million Series A funding round in March. The suite enables R&D finance teams to create customised dashboards traced to trial-level operational data, model scenarios like enrolment delays without affecting actuals, and compare forecast versions. The platform covers the full R&D financial lifecycle, from automated accruals to forecasting and executive reporting. Condor also previewed AI agents built on a clinical and financial ontology developed with Big Four accounting firms. The platform automatically updates as protocols change, unifying data across clinical operations and finance. Condor currently manages over $19 billion in R&D spend for pharmaceutical clients.
Condor's AI-powered platform automatically unifies clinical, operational, and financial data to empower life sciences companies to see, predict, and control the cost of bringing life-changing therapies to patients
New Benchmarking Features Further Empower Biopharma Finance Teams with Automation, Real-Time Insights, and Predictive Capabilities – Accelerating and Improving Decision-Making Across R&DSAN DIEGO, April 9, 2025 /PRNewswire/ -- Condor Software, which created the first financial cloud for biopharma research and development (R&D), today announced significant enhancements to its Forecast and Scenario Planning Suite. Designed specifically for biopharma R&D finance teams, the enhanced suite now includes advanced benchmarking capabilities to complement existing automation, real-time insights, and predictive analytics. These upgrades enable finance leaders to more precisely forecast R&D costs, rapidly model financial scenarios, and accelerate strategic decision-making.This enhanced Forecast and Scenario Planning Suite represents the ongoing expansion of the Condor Cloud, reinforcing Condor's established position as the trusted, industry-leading platform delivering unmatched financial clarity, efficiency, and informed strategic insights across the spectrum of biopharma R&D. The Forecast and Scenario Planning Suite is one of three product suites that comprise the Condor Cloud, one of which is slated for release later this year."Condor is revolutionizing the way biopharma companies manage their clinical research and development finances," said Jennifer Kyle, the company's CEO and Founder. "Our software powers intelligent workflows, aggregates critical clinical and financial data, and drives smarter, faster decisions. This new enhancement enables us to broaden our coverage and insights needed for financial planning, eliminating guesswork with outdated, error-prone processes in an industry where time and innovation are critical
SAN DIEGO, July 30, 2024 /PRNewswire/ --Condor Software, a leader in clinical trial finance and accounting software, today announced a strategic collaboration with Danforth Advisors to provide an integrated solution for clinical finance. By pairing Condor's technology with the support of Danforth's clinical finance consultants, biopharma companies can more efficiently track and manage clinical costs for improved reporting accuracy and forecasting.Without a qualified clinical finance specialist and efficient process, biopharma companies often struggle with financial reporting and creating reliable forecasts. Together, Condor and Danforth offer a proven software solution, implemented and managed by technical finance specialists with deep understanding of the drug development process. This collaboration enhances reporting accuracy, efficiency, and compliance, enabling biopharma teams to focus on science and innovation."Partnering with Danforth Advisors expands our capabilities beyond technology, providing a tailored comprehensive financial solution for the pharma industry," said Jennifer Kyle, CEO of Condor Software. "I've admired Danforth's talent in Clinical, FP&A, and Accounting. Combining their expertise with our technology offers end-to-end solutions, bridging the gap between the clinical and finance, enabling biopharma companies to reach new levels of financial excellence."Danforth Advisors' Dan Dehner, Managing Director, added, "By offering Condor's software with our clinical finance consulting services, we can further streamline this important work for our clients and uphold the integrity of reporting results."Key benefits of the combined software and service include:Accelerated Financial Close: Increased efficiency through streamlined workflows and automations.Increased efficiency through streamlined workflows and automations
SAN DIEGO, May 13, 2024 /PRNewswire/ -- Condor Software, a leading provider of clinical trial financial management software nationwide, announced today that Brice Wu has joined their leadership team as Chief Product and Operations Officer. Brice has more than 20 years of experience in leading technical and services teams across healthcare and life sciences. Brice Wu, Chief Product and Operations Officer. "We are thrilled to welcome Brice to the Condor team," said Jennifer Kyle, Chief Executive Officer at Condor Software. "His experience leading high-performing teams within rapidly growing SaaS companies will help strengthen our technical capabilities and accelerate both future product development and adoption of Condor."In his role, Brice is responsible for leading all product and technology efforts across the Condor software portfolio. Previously, he served as Chief Product Officer for Iterative Health, an AI and Computer Vision based suite of colonoscopy diagnosis solutions, and as the Head of Engineering / Chief Technology Officer at Komodo Health, a leading Enterprise SaaS Healthcare Technology company
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series A
Total Funding
$24M
Headquarters
San Diego, California
Founded
2020
Find jobs on Simplify and start your career today